Intended Use

Aid to the reader during screening of 3D breast ultrasound images produced by the somo.v Automated Breast Ultrasound System, to detect mammography-occult lesions in women with dense breast parenchyma.

Technology

Software package consisting of a CAD engine employing image pattern recognition and artificial neural networks to automatically identify suspicious areas in 3D breast ultrasound images, combined with a viewer to display native ABUS images alongside CAD outputs with highlighted suspicious regions.

Performance

Clinical multi-reader multi-case study demonstrated non-inferior breast cancer detection performance with QVCAD aid compared to ABUS alone, and a statistically significant (33%) reduction in interpretation time. Standalone CAD sensitivity was around 71% for CAD marks and 97% for enhanced dark areas, with specificity varying accordingly. Performance was validated on 185 screening cases including 52 cancer cases.

Device Timeline

  • 1

    Submission

    11/23/2015

    11 months
  • 2

    FDA Approval

    11/9/2016

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.